The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Medical device site abscess 3
RITUXIMAB Metapneumovirus infection 3
Rituximab Metastatic squamous cell carcinoma 3
RITUXIMAB Musculoskeletal disorder 3
RITUXIMAB Musculoskeletal stiffness 3
RITUXIMAB Myalgia 3
Rituximab Myocardial ischaemia 3
RITUXIMAB Nail pigmentation 3
Rituximab Nasal herpes 3
Rituximab Night sweats 3
Rituximab Orbital oedema 3
Rituximab Osteoporosis 3
Rituximab Osteoporotic fracture 3
Rituximab Palmar-plantar erythrodysaesthesia syndrome 3
Rituximab Peripheral arterial occlusive disease 3
RITUXIMAB Pneumocystis jirovecii infection 3
RITUXIMAB Pneumonia cytomegaloviral 3
RITUXIMAB Pneumonia fungal 3
Rituximab Pneumonia pseudomonal 3
Rituximab Post procedural infection 3

Total Records: 1,104     Number of Pages: 56